TY - JOUR
T1 - Clinical Epidemiology in China series. Paper 1
T2 - Evidence-based medicine in China: An oral history study
AU - Li, Bo
AU - Yan, Yumeng
AU - Lv, Meng
AU - Zhao, Guozhen
AU - Li, Zeyu
AU - Feng, Shuo
AU - Hu, Jing
AU - Zhang, Yuqing
AU - Yu, Xuan
AU - Zhang, Jingyi
AU - Ma, Bin
AU - Yang, Kehu
AU - Chen, Yaolong
N1 - Publisher Copyright:
© 2021
PY - 2021/12
Y1 - 2021/12
N2 - Objective: To describe and record the evolution of EBM in China. Study Design and Setting: We conducted the study following the general methodology of oral history. The interviews were done at Lanzhou University, between 18th and 22nd April 2019 using pre-defined questions. All interviews were videorecorded. Two investigators extracted and analyzed the information from the interviews independently. Results: One international expert and ten Chinese experts participated in the interviews. After the introduction of EBM in China in the mid-1990s, more than 20 EBM centres have been established. According to the interviewees, Gordon Guyatt, David Sackett and Iain Chalmers are the international experts who played the most important role in the development of EBM in China. China has contributed to EBM on the international level by conducting systematic reviews, developing reporting checklists, and introducing the principles of EBM into Traditional Medicine. The Chinese Cochrane Centre and the EBM Centre of Lanzhou University were ranked the top two EBM Centres in China by the interviewees. Conclusion: EBM has been developing in China for nearly a quarter of a century. Many achievements have been reached, however, EBM is still facing many challenges in China, including shortages of funding support and personnel, as well as limited local high-quality evidence.
AB - Objective: To describe and record the evolution of EBM in China. Study Design and Setting: We conducted the study following the general methodology of oral history. The interviews were done at Lanzhou University, between 18th and 22nd April 2019 using pre-defined questions. All interviews were videorecorded. Two investigators extracted and analyzed the information from the interviews independently. Results: One international expert and ten Chinese experts participated in the interviews. After the introduction of EBM in China in the mid-1990s, more than 20 EBM centres have been established. According to the interviewees, Gordon Guyatt, David Sackett and Iain Chalmers are the international experts who played the most important role in the development of EBM in China. China has contributed to EBM on the international level by conducting systematic reviews, developing reporting checklists, and introducing the principles of EBM into Traditional Medicine. The Chinese Cochrane Centre and the EBM Centre of Lanzhou University were ranked the top two EBM Centres in China by the interviewees. Conclusion: EBM has been developing in China for nearly a quarter of a century. Many achievements have been reached, however, EBM is still facing many challenges in China, including shortages of funding support and personnel, as well as limited local high-quality evidence.
KW - China
KW - Clinical Epidemiology
KW - Evidence-Based Medicine
KW - Oral History
KW - The Chinese GRADE Centre
KW - Traditional Chinese Medicine
UR - https://www.scopus.com/pages/publications/85115993710
U2 - 10.1016/j.jclinepi.2021.08.012
DO - 10.1016/j.jclinepi.2021.08.012
M3 - Article
C2 - 34416324
AN - SCOPUS:85115993710
SN - 0895-4356
VL - 140
SP - 165
EP - 171
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
ER -